Ceapro Inc. Demonstrates First Water Soluble Solid Nanodispersion Formulation of CoQ10 Utilizing its PGX Enabling Technology
Announces positive results from the first phase of a project to develop a functional energy drink at the 16th European Meeting on Supercritical Fluid Technologies held in Lisbon, Portugal
EDMONTON, ALBERTA--(May 4, 2017) - Ceapro Inc.(TSX VENTURE:CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today the successful completion of the first development phase of a project entitled, "Beta glucan with coenzyme Q10 ("CoQ10"): A novel ingredient for functional beverages." This project included two studies, which were conducted at the University of Alberta by Dr. Feral Temelli's team along with Ceapro researchers.
- Published: 04 May 2017
- Written by Editor